Login    Join free Add to favorites    中文
home > news > 9th Annual Biomarkers Congress 2014(Feb 25-26, Manchester UK)
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
9th Annual Biomarkers Congress 2014(Feb 25-26, Manchester UK)

hits:1583     Date:11/20/13

9th Annual Biomarkers Congress 2014

9th Annual Biomarkers Congress 2014
25th -26th Feb 2014, Manchester UK
250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
55 presentations, case studies and panel discussions focused on the key issues in biomarker research, personalised healthcare and companion diagnostics
6 Interactive Streams:
  • Biomarkers in Discovery & Preclinical Development
  • Companion Diagnostics
  • Biomarker Discovery & Verification
  • Innovations In Biomarker Research
  • Clinical Biomarkers
  • Clinical Trials & Personalised Medicine
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
Oxford Global Conferences are proud to present the 9th Annual Biomarkers Congress, taking place on 25 & 26 February 2014 in Manchester.
The increasing interest in biomarker discovery in recent years has pushed biomarker research into the foreground of the modern pharmaceutical industry. New identification technologies have both widened the scope of biomarker research and underlined the need for robust validation, improved predictive value and the clear demonstration of clinical relevance.
The Biomarkers Congress will cover the latest advances in biomarker discovery and verification, including mass cytometry, selected reaction monitoring and chemical genetics. Our expert speakers will also discuss efforts to increase biomarker sensitivity and specificity through genomic analysis, informatics approaches and better sample management. In the Companion Diagnostics stream, presentations will cover emerging technologies, optimisation of existing platforms and strategies to improve strategic partnerships.
To build on the clinical case studies shared at last year鈥檚 event, we are pleased to introduce the co-located 鈥Biomarkers in Clinical Development Congress鈥, focusing on the role of biomarkers in clinical decision making, drug efficacy prediction and clinical safety. Key decision makers in personalised medicine will complement these discussions with their insights into pharmacogenomics, stratification markers and precision medicine.
In keeping with Oxford Global鈥檚 highly successful life sciences series, an expert panel of over 50 speakers will present a full conference programme covering the topics outlined below:
9th Annual Biomarkers Congress
Day 1 Stream 1: Biomarkers In Discovery & Preclinical Development
  • Safety biomarkers: validation and regulation
  • Biomarker research: key learnings from preclinical models and experimental medicine
  • PK/PD studies: predictive science from a biomarker perspective
  • Imaging biomarkers: new technologies
  • Biomarker outsourcing strategies
  • Capturing real-world data in biomarker research
Day 1 Stream 2: Companion Diagnostics
  • How best to mature emerging technologies into companion diagnostics
  • Companion diagnostics in cancer drug development
  • Human tissue collection in diagnostics research
  • Strategic partnership best practice in companion diagnostics development
  • Optimising targets and platforms for the development of biomedical diagnostics
Day 2 Stream 1: Biomarker Discovery & Verification
  • Biomarker analysis: technologies & platforms
  • Development and validation of challenging biomarker assays
  • Applications of selected reaction monitoring in pharma
  • Informatics in biomarker discovery
  • Mass cytometry: a promising novel technology for biomarker discovery
  • Big data innovation in biomarker research
  • The role of biobanking in biomarker research
Day 2 Stream 2: Innovations In Biomarker Research
  • Collaborative strategies: building on the success of safety biomarker initiatives
  • Latest updates from correlative science teams
  • New advances in circulation tumour cell research
  • Novel biomarker identification methods: exploiting structure and chemical genetics
  • Innovation case studies: oncology and respiratory biomarkers
Biomarkers In Clinical Development Congress
Day 1: Clinical Biomarkers
  • Biomarker development and clinical application
  • Biomarker research: a clinician鈥檚 perspective
  • Translating biomarkers into clinical assays
  • Clinical genetics: developing diagnostic assays with clinical utility
  • Fit for purpose development of clinical biomarkers
  • Successful clinical validation of biomarkers
Day Two: Clinical Trials & Personalised Medicine
  • Advancing personalised medicine: case studies from clinical teams
  • Personalised medicine and pharmacogenomics: the generic company鈥檚 perspective
  • Finding the right patient population: mining clinical study data
  • Precision medicine: updates from large pharma
  • Developing patient selection markers
  • Identifying the right patient for targeted therapy
Who will attend
The 9th Annual Biomarkers Congress is an exclusive event designed for senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies, along with highly esteemed members of academic and government institutions. Delegates typically include VPs, Directors and Global Heads of:
  • Adaptive trial design
  • Assay development
  • Assay validation
  • Biobanking
  • Bioinformatics
  • Biomarker development
  • Biomarker identification
  • Biomarker validation
  • Biomarker discovery
  • Clinical safety
  • Companion diagnostics
  • Immunoassays
  • Patient stratification
  • Personalised medicine
  • Pharmacogenomics
  • PK/PD
  • Precision medicine
  • Rx/Dx co-development
All general enquiries
Tel: +44 (0)1865 248455
Fax: +44 (0)1865 250985
For speaker opportunities contact c.tighe@oxfordglobal.co.uk 
For sponsorship opportunities contact sponsorship@oxfordglobal.co.uk
Related News>> more

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙